BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37233750)

  • 21. Perineural invasion is a poor prognostic factor for sinonasal squamous cell carcinoma.
    Chou CW; Lan MY; Kuo YJ; Yeh CF
    Oral Oncol; 2024 Mar; 150():106698. PubMed ID: 38277976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing Prognostic Value of Quantitative Neck Dissection Quality Measures in Patients With Clinically Node-Negative Oral Cavity Squamous Cell Carcinoma.
    Farrokhian N; Holcomb AJ; Dimon E; Karadaghy O; Ward C; Whiteford E; Tolan C; Hanly EK; Buchakjian MR; Harding B; Dooley L; Shinn J; Wood CB; Rohde S; Khaja S; Parikh A; Bulbul MG; Penn J; Goodwin S; Bur AM
    JAMA Otolaryngol Head Neck Surg; 2022 Oct; 148(10):947-955. PubMed ID: 36074415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
    Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
    JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
    Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
    J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neck dissection for squamous cell carcinoma of the head and neck.
    Santa Maria PL; Sader C; Preston NJ; Fisher PH
    Otolaryngol Head Neck Surg; 2007 Apr; 136(4 Suppl):S41-5. PubMed ID: 17398340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of tumor subsite on survival outcomes in oral squamous cell carcinoma: A retrospective cohort study from 2000 to 2019.
    Justesen MM; Stampe H; Jakobsen KK; Andersen AO; Jensen JM; Nielsen KJ; Gothelf AB; Wessel I; Christensen A; Grønhøj C; von Buchwald C
    Oral Oncol; 2024 Feb; 149():106684. PubMed ID: 38211527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical course and survival in patients with squamous cell carcinoma of the maxillary alveolus and hard palate: Results from a single-center prospective cohort.
    Hakim SG; Steller D; Sieg P; Rades D; Alsharif U
    J Craniomaxillofac Surg; 2020 Jan; 48(1):111-116. PubMed ID: 31884030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical outcome and prognostic factors in recurrent oral squamous cell carcinoma after primary surgical treatment: a retrospective study.
    Zittel S; Moratin J; Horn D; Metzger K; Ristow O; Engel M; Mrosek J; Freier K; Hoffmann J; Freudlsperger C
    Clin Oral Investig; 2022 Feb; 26(2):2055-2064. PubMed ID: 34581884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High rates of regional failure in squamous cell carcinoma of the hard palate and maxillary alveolus.
    Morris LG; Patel SG; Shah JP; Ganly I
    Head Neck; 2011 Jun; 33(6):824-30. PubMed ID: 20949448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prior chemoradiotherapy and pathological perineural invasion predict the survival outcomes of salvage surgery in head and neck squamous cell carcinoma.
    Akali NR; Buggaveeti R; Sukumaran SV; Balasubramanian D; Iyer S; Thankappan K
    Head Neck; 2021 Mar; 43(3):874-883. PubMed ID: 33219731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma.
    Harris BN; Bayoumi A; Rao S; Moore MG; Farwell DG; Bewley AF
    Otolaryngol Head Neck Surg; 2017 May; 156(5):863-869. PubMed ID: 28322123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pretreatment ADC is not a prognostic factor for local recurrences in head and neck squamous cell carcinoma when clinical T-stage is known.
    Peltenburg B; Driessen JP; Vasmel JE; Pameijer FA; Janssen LM; Terhaard CHJ; de Bree R; Philippens MEP
    Eur Radiol; 2020 Feb; 30(2):1228-1231. PubMed ID: 31529258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contralateral lymph node recurrence rate and its prognostic factors in stage IVA-B well-lateralized oral cavity cancer.
    Chien JC; Hu YC; Chang KC; Huang YH; Huang CY; Kang BH; Liu WS
    Auris Nasus Larynx; 2021 Oct; 48(5):991-998. PubMed ID: 33526320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Histologic Risk Factors on Recurrence Rates for Oral Cavity Squamous Cell Carcinoma.
    Kligerman MP; Moon PK; Tusty M; Cloutier JM; Ma Y; Holsinger CF; Divi V
    Ann Otol Rhinol Laryngol; 2023 Jul; 132(7):731-737. PubMed ID: 35899590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncologic Outcomes After Salvage Laryngectomy for Squamous Cell Carcinoma of the Larynx and Hypopharynx: A Multicenter Retrospective Cohort Study.
    Meulemans J; Debacker J; Demarsin H; Vanclooster C; Neyt P; Mennes T; Vauterin T; Huvenne W; Laenen A; Delaere P; Vander Poorten V
    Ann Surg Oncol; 2021 Mar; 28(3):1751-1761. PubMed ID: 32860174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benefits of maxillectomy with internal dissection of the masticator space by transmandibular approach in the surgical management of malignant tumours of the upper gingiva and hard palate: a clinical review of 10 cases.
    Yanamoto S; Yamada S; Takahashi H; Naruse T; Shigeta T; Minamikawa T; Shibuya Y; Komori T; Umeda M
    Int J Oral Maxillofac Surg; 2014 Nov; 43(11):1319-25. PubMed ID: 24993866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary and recurrent regional metastases for lateralized oral cavity squamous cell carcinoma.
    Contrera KJ; Huang AT; Shenson JA; Tang C; Roberts D; Myers JN; Weber RS; Lai SY; Williams M; El-Hallal M; Jacob D; Zafereo M
    Surg Oncol; 2022 Sep; 44():101804. PubMed ID: 35932620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early relapse is an adverse prognostic factor for survival outcomes in patients with oral cavity squamous cell carcinoma: results from a nationwide registry study.
    Tsai CY; Wen YW; Lee SR; Ng SH; Kang CJ; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Hsieh CH; Yeh CH; Lin CH; Tsao CK; Fang TJ; Huang SF; Lee LA; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Cheng NM; Liao CT
    BMC Cancer; 2023 Feb; 23(1):126. PubMed ID: 36750965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elective Neck Dissection in T1N0M0 Oral Squamous Cell Carcinoma: When Is It Necessary?
    Feng Z; Cheng A; Alzahrani S; Li B; Han Z; Ward BB
    J Oral Maxillofac Surg; 2020 Dec; 78(12):2306-2315. PubMed ID: 32730759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TNM 8 staging is a better prognosticator than TNM 7 for patients with locally advanced oral cavity squamous cell carcinoma treated with surgery and post-operative radiotherapy.
    Sambasivan K; Sassoon I; Thavaraj S; Kennedy R; Doss G; Michaelidou A; Odell E; Sandison A; Hall G; Morgan P; Collins LHC; Lyons A; Cascarini L; Fry A; Oakley R; Simo R; Jeannon JP; Petkar I; Reis Ferreira M; Kong A; Lei M; Guerrero Urbano T
    Radiother Oncol; 2021 Jul; 160():54-60. PubMed ID: 33845044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.